CEACAM5 and malignant colon neoplasm: The marker carcinoembryonic antigen (CEA) is recommended by the National Comprehensive Cancer Network (NCCN) guidelines for colon cancer and American Society of Clinical Oncology (ASCO) to test a diagnosis of colon cancer as a baseline for monitoring and then to regularly monitor for recurrence or metastasis of the colon cancer38,39.